Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net loss	$ (25,464)	$ (45,816)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,138	8,761
Stock-based compensation expense	1,879	2,275
Inventory impairments and option contract abandonments	2,921	2,246
Deferred and other income tax provision (benefit)	16	(485)
Changes in allowance for doubtful accounts	(373)	(190)
Equity in (income) loss of unconsolidated entities	(221)	207
Cash distributions of income from unconsolidated entities	567	336
Loss on extinguishment of debt	2,670	1,517
Changes in operating assets and liabilities:
Increase in accounts receivable	(6,284)	(1,277)
(Increase) decrease in income tax receivable	(1,941)	3,292
Increase in inventory	(260,982)	(159,753)
(Increase) decrease in other assets	(626)	559
Increase in trade accounts payable	635	10,357
Decrease in other liabilities	(11,191)	(20,274)
Other changes	(337)	51
Net cash used in operating activities	(289,593)	(198,194)
Cash flows from investing activities:
Capital expenditures	(8,984)	(6,572)
Investments in unconsolidated entities	(4,567)	(1,374)
Return of capital from unconsolidated entities	187	432
Increases in restricted cash	(10,081)	(1,788)
Decreases in restricted cash	1,096	9,035
Net cash used in investing activities	(22,349)	(267)
Cash flows from financing activities:
Repayment of debt	(305,085)	(185,431)
Proceeds from issuance of new debt	325,000	200,000
Debt issuance costs	(5,504)	(4,935)
Settlement of unconsolidated entity debt obligation	0	(500)
Payments for other financing activities	(446)	(122)
Net cash provided by financing activities	13,965	9,012
Decrease in cash and cash equivalents	(297,977)	(189,449)
Cash and cash equivalents at beginning of period	504,459	487,795
Cash and cash equivalents at end of period	$ 206,482	$ 298,346